Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Knight, S, Morris, P
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2008

Παρόμοια τεκμήρια

Mycophenolate mofetil and atherosclerosis
ανά: Z S Alekberova, κ.ά.
Έκδοση: (2009-10-01)

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
ανά: Navamani Kirubakaran, κ.ά.
Έκδοση: (2022-01-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
ανά: Tomoko Mizaki, κ.ά.
Έκδοση: (2023-01-01)

Mycophenolate Mofetil-Induced Pneumatosis Intestinalis
ανά: Daphne Moutsoglou, κ.ά.
Έκδοση: (2024-01-01)

Mycophenolate mofetil in giant cell arteritis
ανά: Anne Pankow, κ.ά.
Έκδοση: (2023-11-01)

Mycophenolate mofetil in the treatment of lupus nephritis
ανά: Patrick FK Yong, κ.ά.
Έκδοση: (2008-06-01)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
ανά: Lan-Fang Li, κ.ά.
Έκδοση: (2023-03-01)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil induced gastrointestinal disorders
ανά: Sanaz Sheikhzadeh, κ.ά.
Έκδοση: (2013-06-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
ανά: L P Ananyeva
Έκδοση: (2009-03-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
ανά: A. I. Dolgushina, κ.ά.
Έκδοση: (2021-12-01)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
ανά: Joyce J. Kim, κ.ά.
Έκδοση: (2020-01-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
ανά: Rebecca M. Yim, κ.ά.
Έκδοση: (2023-03-01)

Management of erythema nodosum leprosum by mycophenolate mofetil
ανά: Banerjee Kalyan, κ.ά.
Έκδοση: (2008-01-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
ανά: Seung Woon Park, κ.ά.
Έκδοση: (2016-06-01)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
ανά: Xuebing Zhang, κ.ά.
Έκδοση: (2020-11-01)

Off-lable uses of mycophenolate mofetil: lupus nephritis
ανά: B. Fernández-García, κ.ά.
Έκδοση: (2015-07-01)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
ανά: Argyris Tzouvelekis, κ.ά.
Έκδοση: (2011-01-01)

Mycophenolate mofetil induced transfusion dependent anemia in lupus
ανά: Anand Prahalad Rao, κ.ά.
Έκδοση: (2018-01-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
ανά: Božić-Majstorović Ljubinka, κ.ά.
Έκδοση: (2024-01-01)

Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
ανά: Swiss Medical Weekly
Έκδοση: (2009-01-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
ανά: A. Hackl, κ.ά.
Έκδοση: (2023-08-01)

Mycophenolate mofetil (CellCept) in patients with autoimmune hepatitis
ανά: Abdo Ayman
Έκδοση: (2006-01-01)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
ανά: Martini G, κ.ά.
Έκδοση: (2008-09-01)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.
ανά: Anoop M Nambiar, κ.ά.
Έκδοση: (2017-01-01)

Recalcitrant lymphocytoma cutis successfully treated with mycophenolate mofetil
ανά: Farhan Mahmood, κ.ά.
Έκδοση: (2021-06-01)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
ανά: Stephanie Del Rio Navarrete Biot, κ.ά.
Έκδοση: (2014-12-01)

Therapeutic efficacy and clinical effectiveness of mycophenolate mofetil and dexamethasone for immune thrombocytopenia: A retrospective observational study
ανά: Nilesh Wasekar, κ.ά.
Έκδοση: (2021-01-01)

Mycophenolate Mofetil as a Potential Therapeutic Option for Neuropsychiatric Lupus: A Case Report
ανά: Warren Weng Seng Fong MBBS, MRCP, κ.ά.
Έκδοση: (2014-12-01)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
ανά: Kyle M. Gardiner, κ.ά.
Έκδοση: (2018-11-01)

Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
ανά: Knight, SR, κ.ά.
Έκδοση: (2009)

In vitro mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others
ανά: Junjun Mao, κ.ά.
Έκδοση: (2024-08-01)

Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil
ανά: Young Gi Min, κ.ά.
Έκδοση: (2024-12-01)

Esophageal Cicatricial Pemphigoid as an Isolated Involvement Treated with Mycophenolate Mofetil
ανά: Sandra Sánchez Prudencio, κ.ά.
Έκδοση: (2015-01-01)

Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil
ανά: Anabela Malho, κ.ά.
Έκδοση: (2010-01-01)

Acquired Perforating Dermatosis: A Disorder Treatable with Mycophenolate Mofetil
ανά: Shaima Al-Bader, κ.ά.
Έκδοση: (2023-12-01)

Management of pemphigoid vegetans with mycophenolate mofetil: A case report
ανά: Audrey Mathieu, κ.ά.
Έκδοση: (2024-02-01)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
ανά: Kelly Z. Young, BA, κ.ά.
Έκδοση: (2022-10-01)

Post COVID‐19 organizing pneumonia treated with mycophenolate mofetil
ανά: Hui Xin Tan, κ.ά.
Έκδοση: (2022-11-01)

"TREATMENT OF CHRONIC PLAQUE TYPE PSORIASIS WITH SYSTEMIC MYCOPHENOLATE MOFETIL "
ανά: S. Toosi R. M. Robati, κ.ά.
Έκδοση: (2006-11-01)

Treatment of severe henoch-schonlein purpura nephritis with mycophenolate mofetil
ανά: Ahmad Ali Nikibakhsh, κ.ά.
Έκδοση: (2014-01-01)